Intervet Orbax (orbifloxacin tablets) 22.7 mg (2 products)
Recall announced April 21, 2022 by Intervet, Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Mislabeling. It affects dogs and cats. The agency has closed this recall.
- Brands
- Orbax
- Where sold
- Nationwide
- Last updated
- November 20, 2026
Products included
- Orbax (orbifloxacin tablets) 22.7 mg, 250 Tablets, Intervet Inc., (d/b/a Merck Animal Health( a subsidiary of Merck and Co., Madison, NJ 07940, NDC 0061-1141-01. (LOT 28010015)
- Orbax (orbifloxacin tablets) 68 mg, 100 Tablets, Intervet Inc., (d/b/a Merck Animal Health( a subsidiary of Merck and Co., Madison, NJ 07940, NDC 0061-1174-01. (LOT 28020014)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
